Diseased Human Peripheral Blood Products, Hematological Cancer

Primary human cells, frozen

Diseased Human Peripheral Blood Products, Hematological Cancer

Primary human cells, frozen

Hematological Cancer, Custom, Frozen
Custom
Catalog # 200-0404

Primary Cells, Frozen

Overview

Start immuno-oncology experiments confidently with a reliable supply of ethically sourced, custom-isolated frozen peripheral blood plasma and serum from donors diagnosed with a hematological cancer.

Primary human plasma is isolated from peripheral blood using centrifugation. Primary human serum is isolated from peripheral blood after coagulation and removal of the fibrin clot and blood cells. All frozen peripheral blood products are obtained from donors diagnosed with a hematological cancer using Institutional Review Board (IRB)-approved consent forms and protocols. Additional documentation to meet institutional requirements is available upon request. Acid-citrate-dextrose (ACD), acid-citrate-dextrose solution A (ACDA), citrate-phosphate-dextrose (CPD), citrate-phosphate-double-dextrose (CP2D), or citrate-phosphate-dextrose-adenine (CPDA) is added during collection as an anticoagulant.

Contact your local sales representative or Product & Scientific Support at techsupport@stemcell.com for donor specifications (BMI category, smoking status, ethnicity, etc.). Donors are screened for HIV-1, HIV-2, hepatitis B, and hepatitis C. Certain products are only available in select territories.

For more information, browse frequently asked questions (FAQs) on primary cells.
Subtype
Frozen
Species
Human
Cell and Tissue Source
Plasma, Serum
Area of Interest
Cancer, Drug Discovery and Toxicity Testing, Stem Cell Biology
Donor Status
Diseased

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
200-0404
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.

Contact STEMCELL Technologies

Our Customer Service, Sales, and Product and Scientific Support departments in North America are available between 6 am and 5 pm Pacific Time (9 am and 8 pm Eastern Time). One of our representatives will be happy to help you by telephone or email. Please complete the form to contact us by email. A representative will get back to you shortly.
  •  

StemCell Technologies Inc. and affiliates ("STEMCELL Technologies") does not share your email address with third parties. StemCell Technologies Inc. will use your email address to confirm your identity and send you newsletters, transaction-related emails, promotional and customer service emails in accordance with our privacy policy. You can change your email preferences at any time.